600252 Stock Overview
Guangxi Wuzhou Zhongheng Group Co., Ltd. researches, develops, manufactures, and sells pharmaceuticals in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Guangxi Wuzhou Zhongheng Group Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.25 |
| 52 Week High | CN¥2.79 |
| 52 Week Low | CN¥1.90 |
| Beta | 0.39 |
| 1 Month Change | -0.88% |
| 3 Month Change | -4.26% |
| 1 Year Change | -12.79% |
| 3 Year Change | -22.41% |
| 5 Year Change | -30.34% |
| Change since IPO | 291.89% |
Recent News & Updates
Guangxi Wuzhou Zhongheng GroupLtd (SHSE:600252) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Apr 05
Guangxi Wuzhou Zhongheng GroupLtd (SHSE:600252) Has Debt But No Earnings; Should You Worry?
Mar 15Shareholder Returns
| 600252 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.9% | 3.0% | 1.6% |
| 1Y | -12.8% | -12.9% | -15.1% |
Return vs Industry: 600252 matched the CN Pharmaceuticals industry which returned -12.9% over the past year.
Return vs Market: 600252 exceeded the CN Market which returned -15.1% over the past year.
Price Volatility
| 600252 volatility | |
|---|---|
| 600252 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 600252 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600252's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 2,886 | Yidong Ni | www.wz-zhongheng.com |
Guangxi Wuzhou Zhongheng Group Co., Ltd. researches, develops, manufactures, and sells pharmaceuticals in China. The company offers xueshuantong for injection, zhonghua dieda pills, fuyanjing capsules, jieshitong tablets, yanjianning tablets, angong niuhuang pills, shedan chuanbei liquid, and fluorescein sodium injection covers range of therapeutic areas, such as cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and other fields.
Guangxi Wuzhou Zhongheng Group Co.,Ltd Fundamentals Summary
| 600252 fundamental statistics | |
|---|---|
| Market cap | CN¥7.75b |
| Earnings (TTM) | CN¥84.31m |
| Revenue (TTM) | CN¥3.10b |
91.9x
P/E Ratio2.5x
P/S RatioIs 600252 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600252 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.10b |
| Cost of Revenue | CN¥1.22b |
| Gross Profit | CN¥1.88b |
| Other Expenses | CN¥1.79b |
| Earnings | CN¥84.31m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 0.024 |
| Gross Margin | 60.65% |
| Net Profit Margin | 2.72% |
| Debt/Equity Ratio | 21.4% |
How did 600252 perform over the long term?
See historical performance and comparison